TransMedics Group, Inc. (TMDX) stock
TMDXNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 15/3029% below fair value
$91.38−0.62 (-0.67%)
Close on Nov 13, 2026Market cap $3.17BP/E 25.0Yield 0.00%
TransMedics profit margin
Profit margin (net margin) is net income as a percentage of revenue.
TransMedics's profit margin for the twelve months ending Sep 30, 2026 was 19.9%. For fiscal 2025 it was 31.4%, against 8.0% the year before. The highest annual figure on record is 31.4% in fiscal 2025.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 31.4% | +23.4 |
| FY2024 | Dec 31, 2024 | 8.0% | +18.4 |
| FY2023 | Dec 31, 2023 | -10.4% | +28.4 |
| FY2022 | Dec 31, 2022 | -38.8% | +107.3 |
| FY2021 | Dec 31, 2021 | -146.1% | −34.0 |
| FY2020 | Dec 31, 2020 | -112.1% | +30.0 |
| FY2019 | Dec 28, 2019 | -142.1% | +40.4 |
| FY2018 | Dec 29, 2018 | -182.5% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 8.4% | −8.5 |
| Q2 FY2026 | Jun 30, 2026 | 7.7% | −14.5 |
| Q1 FY2026 | Mar 31, 2026 | 4.2% | −13.7 |
| Q4 FY2025 | Dec 31, 2025 | 65.6% | +59.9 |
| Q3 FY2025 | Sep 30, 2025 | 16.9% | +13.0 |
| Q2 FY2025 | Jun 30, 2025 | 22.2% | +11.5 |
| Q1 FY2025 | Mar 31, 2025 | 17.9% | +5.3 |
| Q4 FY2024 | Dec 31, 2024 | 5.6% | +0.7 |
| Q3 FY2024 | Sep 30, 2024 | 3.9% | +42.1 |
| Q2 FY2024 | Jun 30, 2024 | 10.7% | +12.6 |
| Q1 FY2024 | Mar 31, 2024 | 12.6% | +18.9 |
| Q4 FY2023 | Dec 31, 2023 | 5.0% | +26.4 |
| Q3 FY2023 | Sep 30, 2023 | -38.3% | −9.4 |
| Q2 FY2023 | Jun 30, 2023 | -1.9% | +54.2 |
| Q1 FY2023 | Mar 31, 2023 | -6.3% | +60.2 |
| Q4 FY2022 | Dec 31, 2022 | -21.4% | +109.6 |
| Q3 FY2022 | Sep 30, 2022 | -28.9% | +212.5 |
| Q2 FY2022 | Jun 30, 2022 | -56.2% | +74.4 |
| Q1 FY2022 | Mar 31, 2022 | -66.5% | +45.7 |
| Q4 FY2021 | Dec 31, 2021 | -131.0% | −48.3 |
| Q3 FY2021 | Sep 30, 2021 | -241.4% | −169.6 |
| Q2 FY2021 | Jun 30, 2021 | -130.6% | +120.0 |
| Q1 FY2021 | Mar 31, 2021 | -112.3% | +5.3 |
| Q4 FY2020 | Dec 31, 2020 | -82.7% | +68.8 |
| Q3 FY2020 | Sep 30, 2020 | -71.8% | +43.2 |
| Q2 FY2020 | Jun 30, 2020 | -250.6% | −88.3 |
| Q1 FY2020 | Mar 31, 2020 | -117.6% | +29.9 |
| Q4 FY2019 | Dec 28, 2019 | -151.5% | +63.9 |
| Q3 FY2019 | Sep 28, 2019 | -114.9% | +11.5 |
| Q2 FY2019 | Jun 29, 2019 | -162.3% | +47.5 |
| Q1 FY2019 | Mar 30, 2019 | -147.5% | +47.1 |
| Q4 FY2018 | Dec 29, 2018 | -215.4% | – |
| Q3 FY2018 | Sep 29, 2018 | -126.4% | – |
| Q2 FY2018 | Jun 30, 2018 | -209.8% | – |
| Q1 FY2018 | Mar 31, 2018 | -194.6% | – |
See a number that looks wrong?